Skip to main content
. 2020 Jul 10;10:11429. doi: 10.1038/s41598-020-68134-8

Table 4.

Pharmacokinetic parameters and toxicity prediction of research compounds.

Designed compounds miLogP TPSA (Å2) MW (g/mol) LD50 (mg/kg) Toxicity prediction*
1 2.9 65.72 262.27 1,000 4
2 3.29 81.25 277.28 1,000 4
3 3.13 54.87 300.32 1,000 4
4 3.52 70.39 315.33 1,000 4
6a 6.58 147.64 624.66 1,000 4
6b 6.21 157.34 714.74 1,000 4
6c 6.41 156.87 654.68 1,000 4
6d 6.62 156.87 654.68 1,000 4
6e 6.64 156.87 654.68 1,000 4
6f 6.79 156.87 668.71 1,000 4
6g 6.99 156.87 668.71 1,000 4
6h 7.01 156.87 668.71 1,000 4
6i 7.29 156.87 682.74 1,000 4
6k 7.49 156.87 682.74 1,000 4
6l 7.52 156.87 682.74 1,000 4
6m 3.14 104.34 429.48 1,000 4
6n 4.05 104.34 469.55 1,000 4
6o 2.79 118.93 452.48 1,000 4
6p 2.99 113.58 471.52 1,000 4
Ellipticine 4.28 28.68 246.31 178 3

*Toxicity prediction class: 1 → 6 (High toxicity to non-toxic).

HHS Vulnerability Disclosure